Diagnostics & life sciences
Verhaert understands the innovation drivers and challenges the biopharma and medtech industry are facing: from near patient testing to convergence between technologies. We tackle them by our managed, multidisciplinary innovation services. We focus on life science and lab instrumentation, in vitro diagnostics (IVD), and point-of-care diagnostics.
Near patient testing, the empowered patient, usability, increased throughput in drug discovery and production, convergence between technologies like digital technology and biology, are innovation drivers for the biopharma and medtech industry.
Radically new application and business concepts appear in multiple areas: personalized medicine, point-of-care diagnostic systems, mobile health and trials-of-the-future. These emerging concepts have one thing in common: a shift to a more patient centricity.
Quality control instruments
To guarantee the throughput and quality of lab processes in life science R&D, high complex and precision analytical lab instruments are necessary. To deal with these challenges, Verhaert offers lab process optimizations and risk management tools across multiple industries.
In Vitro Diagnostics (IVD)
IVD devices become smaller and more accessible for a wider range of users and new assay and sensing technologies Verhaert supports IVD players to integrate those new technologies, adapt the devices to new markets or make them ready for production.
The delivery of successful point-of-care systems requires a thorough understanding of the intended use environment, user experience and performance of the system. A multidisciplinary approach is essential, which Verhaert provides through its managed innovation services.